Literature DB >> 16985942

New advances in the treatment of hypogonadism in the aging male.

Christopher P Steidle.   

Abstract

The signs and symptoms of low testosterone in the aging male include erectile dysfunction, decreased libido, mood disturbances such as depression, loss of muscle mass, osteoporosis, and increase in body fat. Many of these signs and symptoms were previously believed to be part of the normal aging process, and only recently has treatment of low testosterone in the aging male been shown to provide long-term physical and mental improvement. In the past, oral and injectable testosterone delivery methods had disadvantages that limited their use, but the introduction of transdermal testosterone patches has allowed testosterone to be delivered into the circulation in a consistent fashion. Long-term use of these patches over the last 3 to 10 years has been effective in maintaining sexual function and bone and muscle mass, and from short-term studies it does not appear that testosterone treatment puts men at risk for the development of prostate cancer. A new topical gel formation (Testim) has been designed to provide consistent transdermal absorption of testosterone over 24 hours after a single dose.

Entities:  

Year:  2003        PMID: 16985942      PMCID: PMC1502320     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  5 in total

Review 1.  Andropause: clinical implications of the decline in serum testosterone levels with aging in men.

Authors:  Alvin M Matsumoto
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-02       Impact factor: 6.053

2.  Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel.

Authors:  T Marbury; E Hamill; R Bachand; T Sebree; T Smith
Journal:  Biopharm Drug Dispos       Date:  2003-04       Impact factor: 1.627

3.  Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men.

Authors:  A S Dobs; A W Meikle; S Arver; S W Sanders; K E Caramelli; N A Mazer
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

4.  Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.

Authors:  C Wang; R S Swerdloff; A Iranmanesh; A Dobs; P J Snyder; G Cunningham; A M Matsumoto; T Weber; N Berman
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

5.  AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.

Authors:  C Steidle; S Schwartz; K Jacoby; T Sebree; T Smith; R Bachand
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.